Literature DB >> 23959740

Postoperative arrhythmia in patients with bidirectional cavopulmonary anastomosis.

Alessandra Reichlin1, René Prêtre, Hitendu Dave, Maja I Hug, Matthias Gass, Christian Balmer.   

Abstract

OBJECTIVES: Bidirectional cavopulmonary anastomosis (BDCPA) is part of the staged Fontan palliation for congenital heart defects with single-ventricle morphology. The aim of this study was to describe incidence and characteristics of early postoperative arrhythmias in patients undergoing BDCPA.
METHODS: Retrospective analysis of 60 patients undergoing BDCPA at the age of <12 months from 2001 to 2008 at a single centre. Arrhythmias were subclassified in sinus bradycardia, premature atrial/ventricular contraction, supraventricular tachycardia and atrioventricular block. The groups were compared according to age at operation and diagnosis. Postoperative follow-up data were included until Fontan completion.
RESULTS: Postoperative arrhythmia was observed in 20 patients: 12 temporary and 8 persisting until hospital discharge. Sinus bradycardia is a common postoperative arrhythmia and occurred in 16 patients (9 transient, 7 persistent until hospital discharge). One patient undergoing BDCPA and a Damus-Kaye-Stansel procedure had a persisting first-degree atrioventricular block. The occurrence of a postoperative arrhythmia was independent of age and diagnostic group (hypoplastic left heart vs non-hypoplasic left heart). After hospital discharge, five of the eight arrhythmia resolved spontaneously resulting in 2 patients with sinus bradycardia and 1 patient with a first-degree AV block immediately before the Fontan completion was undertaken.
CONCLUSIONS: Postoperative arrhythmias in patients with BDCPA occur early after surgery and are temporary. Severe and life-threatening arrhythmias are rare although the interventions are complex and the patients very young. The most common arrhythmia is sinus bradycardia.

Entities:  

Keywords:  Arrhythmia; Bidirectional cavopulmonary anastomosis; Congenital heart disease; Infant; Univentricular heart

Mesh:

Year:  2013        PMID: 23959740     DOI: 10.1093/ejcts/ezt420

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  The effects of dexmedetomidine administration on the pulmonary artery pressure and the transpulmonary pressure gradient after the bidirectional superior cavopulmonary shunt.

Authors:  Shinichi Nishibe; Hirokazu Imanishi; Tsutomu Mieda; Miki Tsujita
Journal:  Pediatr Cardiol       Date:  2014-08-12       Impact factor: 1.655

2.  Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network.

Authors:  Matthew E Oster; Shan Chen; Nicholas Dagincourt; Yaniv Bar-Cohen; Matthew Brothers; Nicole Cain; Steven D Colan; Richard J Czosek; Jamie A Decker; David G Gamboa; Salim F Idriss; Joel A Kirsh; Martin J LaPage; Richard G Ohye; Elizabeth Radojewski; Maully Shah; Eric S Silver; Anoop K Singh; Joel D Temple; John Triedman; Jonathan R Kaltman
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-16       Impact factor: 5.209

3.  Arrhythmias Following Comprehensive Stage II Surgical Palliation in Single Ventricle Patients.

Authors:  Carolyn M Wilhelm; Diane Paulus; Clifford L Cua; Naomi J Kertesz; John P Cheatham; Mark Galantowicz; Richard P Fernandez
Journal:  Pediatr Cardiol       Date:  2015-12-14       Impact factor: 1.655

4.  Electrophysiology Study for Complex Supraventricular Tachycardia in Congenital Heart Disease Patients With Single-Ventricle Physiology.

Authors:  Shuenn-Nan Chiu; Jou-Kou Wang; Chun-Wei Lu; Kun-Lang Wu; Wei-Chieh Tseng; Mei-Hwan Wu
Journal:  J Am Heart Assoc       Date:  2016-10-31       Impact factor: 5.501

5.  Preoperative single ventricle function determines early outcome after second-stage palliation of single ventricle heart.

Authors:  Jacek Pająk; Michał Buczyński; Piotr Stanek; Grzegorz Zalewski; Marek Wites; Lesław Szydłowski; Bogusław Mazurek; Lidia Tomkiewicz-Pająk
Journal:  Cardiovasc Ultrasound       Date:  2017-09-11       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.